Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis
Objective: To assess the long-term effects including all-cause mortality, cardiovascular mortality, and fracture incidence, of cinacalcet on secondary hyperparathyroidism (SHPT) in patients on dialysis. Methods: PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched fro...
Saved in:
Main Authors: | Yuan Zu (Author), Xiangxue Lu (Author), Jinghong Song (Author), Ling Yu (Author), Han Li (Author), Shixiang Wang (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Neutrophil-to-Lymphocyte Ratio is a Significant Predictor of Cardiovascular and All-Cause Mortality in Patients Undergoing Peritoneal Dialysis
by: Xiangxue Lu, et al.
Published: (2018) -
High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All-Cause Mortality in Chinese Maintenance Hemodialysis Patients
by: Xiangxue Lu, et al.
Published: (2020) -
Association between Serum Magnesium and Erythropoietin Responsiveness in Hemodialysis Patients: A Cross-Sectional Study
by: Ling Yu, et al.
Published: (2019) -
Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012) -
PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015)